SLC39A6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.825600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.178400E-01
Normal-vs-Stage2
5.449000E-01
Normal-vs-Stage3
2.747800E-01
Normal-vs-Stage4
7.586400E-01
Stage1-vs-Stage2
3.058000E-01
Stage1-vs-Stage3
1.779970E-01
Stage1-vs-Stage4
6.187000E-01
Stage2-vs-Stage3
5.368200E-01
Stage2-vs-Stage4
8.055000E-01
Stage3-vs-Stage4
3.800000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.970000E-01
Normal-vs-AfricanAmerican
9.872800E-01
Normal-vs-Asian
1.470040E-01
Caucasian-vs-AfricanAmerican
7.327200E-01
Caucasian-vs-Asian
9.387700E-02
AfricanAmerican-vs-Asian
6.901500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.235600E-01
Normal-vs-Female
8.740400E-01
Male-vs-Female
4.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.606400E-01
Normal-vs-Age(41-60Yrs)
8.038800E-01
Normal-vs-Age(61-80Yrs)
5.990400E-01
Normal-vs-Age(81-100Yrs)
3.122000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.523800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.535000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.042400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.844100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.305800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.764200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.770300E-02
Normal-vs-Daily Drinker
3.710800E-01
Normal-vs-Weekly Drinker
6.852200E-01
Normal-vs-Occasional Drinker
7.853800E-01
Normal-vs-Social Drinker
7.939400E-01
Non Drinker-vs-Daily Drinker
3.008400E-01
Non Drinker-vs-Weekly Drinker
9.922200E-02
Non Drinker-vs-Occasional Drinker
1.083760E-02
Non Drinker-vs-Social Drinker
7.217700E-02
Daily Drinker-vs-Weekly Drinker
4.138400E-01
Daily Drinker-vs-Occasional Drinker
4.824200E-02
Daily Drinker-vs-Social Drinker
1.590810E-01
Weekly Drinker-vs-Occasional Drinker
2.751200E-01
Weekly Drinker-vs-Social Drinker
3.407000E-01
Occasional Drinker-vs-Social Drinker
8.681400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.069400E-01
Normal-vs-Grade 2
9.346200E-01
Normal-vs-Grade 3
9.222200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.135960E-01
Grade 1-vs-Grade 3
1.433440E-01
Grade 1-vs-Grade 4
6.069400E-01
Grade 2-vs-Grade 3
8.432000E-01
Grade 2-vs-Grade 4
9.346200E-01
Grade 3-vs-Grade 4
9.222200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.912000E-01
Normal-vs-NonDiabetic
8.328400E-01
Diabetic-vs-NonDiabetic
2.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.829600E-02
Normal-vs-NoPancreatitis
8.219600E-01
Pancreatitis-vs-NoPancreatitis
7.044300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.036200E-01
Normal-vs-N1
6.072200E-01
N0-vs-N1
5.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.201600E-01
Normal-vs-TP53-NonMutant
9.229400E-01
TP53-Mutant-vs-TP53-NonMutant
3.227700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
